1 |
J. Bernstein, "Polymorphism in molecular crystals", (Oxford University Press, New York, 2002) p. 1.
|
2 |
W. Jones, W.D.S. Motherwell and A.V. Trask, "Pharmaceutical cocrystals: an emerging approach to physical property enhancement", MRS Bull. 31 (2006) 875.
DOI
|
3 |
G.G.Z. Zhang and D. Zhou, "Crystalline and amorphous solids" in Developing Solid Oral Dosage Forms, Y. Qiu, Y. Chen, G.G.Z. Zhang, L. Liu and W.R. Porter, Eds. (Academic Press, New York, 2009) p. 25.
|
4 |
N. Shan and M.J. Zaworotko, "The role of cocrystals in pharmaceutical science", Drug Discov. Today 13 (2008) 440.
DOI
|
5 |
D.J. Berry, C.C. Seaton, W. Clegg, R.W. Harrington, S.J. Coles, P.N. Horton, M.B. Hursthouse, R. Storey, W. Jones, T. Friscic and N. Blagden, "Applying hot-stage microscopy to co-crystal screening: a study of nicotinamide with seven active pharmaceutical ingredients", Cryst. Growth & Des. 8 (2008) 1697.
DOI
|
6 |
T. Friscic and W. Jones, "Recent advances in understanding the mechanism of cocrystal formation via grinding", Cryst. Growth & Des. 9 (2009) 1621.
DOI
|
7 |
A.L. Kelly, T. Gough, R.S. Dhumal, S.A. Halsey and A. Paradkar, "Monitoring ibuprofen-nicotinamide cocrystal formation during solvent free continuous cocrystallization (SFCC) using near infrared spectroscopy as a PAT tool" Int. J. Pharm. 426 (2012) 15.
DOI
|
8 |
T. Friscic and W. Jones, "Cocrystal architecture and properties: design and building of chiral and racemic structures by solid-solid reactions", Faraday Discuss. 136 (2007) 167.
DOI
|
9 |
F.L.F. Soares and R.L. Carneiro, "Green synthesis of ibuprofen-nicotinamide cocrystals and in-line evaluation by Raman spectroscopy", Cryst. Growth Des. 13 (2013) 1510.
DOI
|
10 |
D.-J. Lee, S. Lee and I.W. Kim, "Effects of humidity and surfaces on the melt crystallization of ibuprofen", Int. J. Mol. Sci. 13 (2012) 10296.
DOI
|
11 |
T. Hino and J.L. Ford, "Characterization of the hydroxypropylmethylcellulose- nicotinamide binary system", Int. J. Pharm. 219 (2001) 39.
DOI
|
12 |
J. Jang and I.W. Kim, "Poly(acrylic acid) to induce competitive crystallization of a theophylline/oxalic acid cocrystal and a theophylline polymorph", J. Cryst. Growth 434 (2016) 104.
DOI
|